AU505416B2 - Improving the compatibility of gamma globulins - Google Patents

Improving the compatibility of gamma globulins

Info

Publication number
AU505416B2
AU505416B2 AU87921/75A AU8792175A AU505416B2 AU 505416 B2 AU505416 B2 AU 505416B2 AU 87921/75 A AU87921/75 A AU 87921/75A AU 8792175 A AU8792175 A AU 8792175A AU 505416 B2 AU505416 B2 AU 505416B2
Authority
AU
Australia
Prior art keywords
compatibility
improving
gamma globulins
globulins
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU87921/75A
Other languages
English (en)
Other versions
AU8792175A (en
Inventor
W. Wolter D Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armour Pharmaceutical Co
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Publication of AU8792175A publication Critical patent/AU8792175A/en
Application granted granted Critical
Publication of AU505416B2 publication Critical patent/AU505416B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU87921/75A 1975-01-02 1975-12-30 Improving the compatibility of gamma globulins Expired AU505416B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
DEDE2500076 1975-01-02

Publications (2)

Publication Number Publication Date
AU8792175A AU8792175A (en) 1977-07-14
AU505416B2 true AU505416B2 (en) 1979-11-22

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87921/75A Expired AU505416B2 (en) 1975-01-02 1975-12-30 Improving the compatibility of gamma globulins

Country Status (20)

Country Link
JP (1) JPS5512001B2 (US08088816-20120103-C00036.png)
AT (1) AT344883B (US08088816-20120103-C00036.png)
AU (1) AU505416B2 (US08088816-20120103-C00036.png)
BE (1) BE837211A (US08088816-20120103-C00036.png)
CA (1) CA1058075A (US08088816-20120103-C00036.png)
DD (1) DD121875A5 (US08088816-20120103-C00036.png)
DE (1) DE2500076C3 (US08088816-20120103-C00036.png)
DK (1) DK144679C (US08088816-20120103-C00036.png)
EG (1) EG11987A (US08088816-20120103-C00036.png)
ES (1) ES443982A1 (US08088816-20120103-C00036.png)
FR (1) FR2296429A1 (US08088816-20120103-C00036.png)
GB (1) GB1495159A (US08088816-20120103-C00036.png)
IE (1) IE43449B1 (US08088816-20120103-C00036.png)
IL (1) IL48766A (US08088816-20120103-C00036.png)
IN (1) IN143525B (US08088816-20120103-C00036.png)
NL (1) NL179824C (US08088816-20120103-C00036.png)
PL (1) PL99599B1 (US08088816-20120103-C00036.png)
SE (1) SE437470B (US08088816-20120103-C00036.png)
SU (1) SU576898A3 (US08088816-20120103-C00036.png)
ZA (1) ZA758050B (US08088816-20120103-C00036.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
KR101439828B1 (ko) 2005-11-30 2014-09-17 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
KR20080090408A (ko) 2005-11-30 2008-10-08 아보트 러보러터리즈 항-Aβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
CN103298833B (zh) 2010-08-14 2015-12-16 Abbvie公司 β淀粉样蛋白结合蛋白

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (US08088816-20120103-C00036.png) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (US08088816-20120103-C00036.png) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
ZA758050B (en) 1976-12-29
IE43449B1 (en) 1981-02-25
SU576898A3 (ru) 1977-10-15
PL99599B1 (pl) 1978-07-31
EG11987A (en) 1981-12-31
AT344883B (de) 1978-08-10
AU8792175A (en) 1977-07-14
DK144679C (da) 1982-10-11
FR2296429A1 (fr) 1976-07-30
DK144679B (da) 1982-05-10
JPS5512001B2 (en) 1980-03-29
IL48766A (en) 1979-11-30
DK584375A (da) 1976-07-03
ES443982A1 (es) 1977-07-16
IE43449L (en) 1976-07-02
CA1058075A (en) 1979-07-10
NL179824C (nl) 1986-11-17
FR2296429B1 (US08088816-20120103-C00036.png) 1978-12-01
DD121875A5 (US08088816-20120103-C00036.png) 1976-09-05
GB1495159A (en) 1977-12-14
DE2500076C3 (de) 1982-11-18
DE2500076B2 (de) 1979-02-22
IN143525B (US08088816-20120103-C00036.png) 1977-12-17
ATA981675A (de) 1977-12-15
NL7514627A (nl) 1976-07-06
SE437470B (sv) 1985-03-04
JPS5191321A (en) 1976-08-10
DE2500076A1 (de) 1976-07-08
SE7514388L (sv) 1976-07-05
BE837211A (fr) 1976-06-30
NL179824B (nl) 1986-06-16
IL48766A0 (en) 1976-02-29

Similar Documents

Publication Publication Date Title
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU505416B2 (en) Improving the compatibility of gamma globulins
AU1230276A (en) Amidinoureas
CA1034488A (en) Seal
CA1034906A (en) Novelty closure
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU501533B2 (en) Closure
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU501362B2 (en) Cephalosporins
AU506584B2 (en) Cephalosporins
AU501766B2 (en) Cephalosporins
AU1393076A (en) Dihydromocimycin
AU1398876A (en) Aryl-di-thioureas
AU505141B2 (en) Cephalosporins
AU502402B2 (en) Cephalosporins
CA1026800A (en) Hydro-air fitting
AU1460876A (en) 6-aminomethylated 3-oxygenated chloest-5-enes
AU1492376A (en) Alpha-pyrones
AU502470B2 (en) Debismuthising lead
AU481303B2 (en) An improved closure